- Advertisement -

Related

Norron Cheers Hansa Medical Fast Track Designation

- Advertisement -

Stockholm (Hedgenordic) – The share price of Swedish Hansa Medical, a biopharmaceutical company focusing on treatments for rare and severe autoimmune conditions, jumped higher Wednesday morning on the news that the U.S. Food and Drug Administration (FDA) had granted imlifidase Fast Track Designation for the investigation of imlifidase for transplantation.

Among funds having significant holdings in the company is Norron Alpha and Norron Active from Swedish hedge fund manager Norron. According to Morningstar, Hansa Medical has a portfolio weight of 4.3 percent in the two respective funds.

In a comment to the news, Gustaf Sjögren (pictured), portfolio manager at Norron says:

“The news from Hansa today, that a fast track designation has been granted by the FDA, is positive and means that they will speed up the process as the treatment is believed to be important enough. This does not mean that the probability of the treatment being approved is higher, but it is already within the 80-85 percent probability range.”

“We hope that today´s news will shorten the approval process by a number of months, meaning  that the company will have a drug ready for the market by Q4 2019.”

Hansa Medical trades 7 percent higher by midday Wednesday at SEK 330 per share, having traded as high as SEK 343 per share earlier in the session.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by the HedgeNordic editorial team.

Latest Articles

ALCUR Turns to ISEC for Fund Services

Stockholm-based boutique ALCUR Fonder has appointed ISEC as its fund administrator and risk manager, as the firm looks to strengthen its operational infrastructure and...

Nordic Hedge Funds Start Final Quarter in the Red

Nordic hedge funds entered the final quarter of the year on the back foot. The Nordic Hedge Index fell 1.4 percent in October, with...

Afa Försäkring Puts Operational Value Creation at the Centre of Private Equity

The challenging private equity environment, marked by higher financing costs, slower distributions and difficult exit conditions, is putting greater pressure on managers to demonstrate...

Thorbjörn Wallentin Parts Ways with OQAM as Credit Takes Centre Stage

After more than a decade helping build Malmö-based asset management firm OQAM, co-founder and Chief Investment Officer Thorbjörn Wallentin is stepping away from his...

The Investment Case for European Infrastructure Debt

Europe’s infrastructure needs are expanding as governments and businesses seek greater energy security, lower emissions and more resilient digital and electricity networks. For debt...

Bliwa Balances Fixed Income Stability with Selective Risk-Taking

For insurers, fixed income must do more than generate returns. It needs to provide stability, preserve liquidity, and help match investments to liabilities. At...

Allocator Interviews

Voices

Request for Proposal

- Advertisement -